CHEBI:80131 - apelin-13

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name apelin-13
ChEBI ID CHEBI:80131
Definition A 13 amino acid oligopeptide which is the ligand for the apelin receptor (also known as the APJ receptor). It exhibits hypotensive and neuroprotective effects, and may be a potential prognostic biomarker for acute ischemic stroke and multiple sclerosis.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
Formula C69H111N23O16S
Net Charge 0
Average Mass 1550.850
Monoisotopic Mass 1549.82999
InChI InChI=1S/C69H111N23O16S/c1-39(2)32-47(86-58(98)44(17-9-26-78-68(73)74)83-63(103)52-20-12-29-91(52)65(105)45(18-10-27-79-69(75)76)84-56(96)42(71)22-23-54(72)94)59(99)89-50(37-93)61(101)87-48(34-41-35-77-38-81-41)60(100)82-43(16-7-8-25-70)57(97)80-36-55(95)90-28-11-19-51(90)62(102)85-46(24-31-109-3)66(106)92-30-13-21-53(92)64(104)88-49(67(107)108)33-40-14-5-4-6-15-40/h4-6,14-15,35,38-39,42-53,93H,7-13,16-34,36-37,70-71H2,1-3H3,(H2,72,94)(H,77,81)(H,80,97)(H,82,100)(H,83,103)(H,84,96)(H,85,102)(H,86,98)(H,87,101)(H,88,104)(H,89,99)(H,107,108)(H4,73,74,78)(H4,75,76,79)/t42-,43-,44-,45-,46-,47-,48-,49-,50-,51-,52-,53-/m0/s1
InChIKey XXCCRHIAIBQDPX-PEWBXTNBSA-N
SMILES N(C(=O)[C@H]1N(CCC1)C([C@H](CCSC)NC(=O)[C@H]2N(CCC2)C(=O)CNC([C@H](CCCCN)NC([C@H](CC3=CN=CN3)NC([C@H](CO)NC([C@H](CC(C)C)NC([C@H](CCCNC(=N)N)NC(=O)[C@H]4N(CCC4)C([C@H](CCCNC(=N)N)NC([C@H](CCC(=O)N)N)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](C(=O)O)CC=5C=CC=CC5
Roles Classification
Chemical Role(s): Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
Biological Role(s): autophagy inhibitor
Any compound that inhibits the process of autophagy (the self-digestion of one or more components of a cell through the action of enzymes originating within the same cell).
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
Application(s): antihypertensive agent
Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism.
biomarker
A substance used as an indicator of a biological state.
neuroprotective agent
Any compound that can be used for the treatment of neurodegenerative disorders.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing apelin-13 (CHEBI:80131) has role antihypertensive agent (CHEBI:35674)
apelin-13 (CHEBI:80131) has role autophagy inhibitor (CHEBI:88230)
apelin-13 (CHEBI:80131) has role biomarker (CHEBI:59163)
apelin-13 (CHEBI:80131) has role human metabolite (CHEBI:77746)
apelin-13 (CHEBI:80131) has role neuroprotective agent (CHEBI:63726)
apelin-13 (CHEBI:80131) is a oligopeptide (CHEBI:25676)
apelin-13 (CHEBI:80131) is conjugate base of apelin-13(3+) (CHEBI:147395)
Incoming apelin-13(3+) (CHEBI:147395) is conjugate acid of apelin-13 (CHEBI:80131)
IUPAC Name
L-glutaminyl-L-arginyl-L-prolyl-L-arginyl-L-leucyl-L-seryl-L-histidyl-L-lysylglycyl-L-prolyl-L-methionyl-L-prolyl-L-phenylalanine
Synonyms Sources
apelin 13 ChEBI
apelin-13 peptide HMDB
Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe ChEBI
L-Gln-L-Arg-L-Pro-L-Arg-L-Leu-L-Ser-L-His-L-Lys-L-Gly-L-Pro-L-Met-L-Pro-L-Phe ChEBI
Q-R-P-R-L-S-H-K-G-P-M-P-F ChEBI
QRPRLSHKGPMPF ChEBI
Manual Xrefs Databases
C15855 KEGG COMPOUND
FDB029200 FooDB
HMDB0012894 HMDB
View more database links
Registry Number Type Source
217082-58-1 CAS Registry Number ChemIDplus
Citations Waiting for Citations Types Sources
15486224 PubMed citation Europe PMC
24755525 PubMed citation Europe PMC
27258138 PubMed citation Europe PMC
29178631 PubMed citation Europe PMC
29336478 PubMed citation Europe PMC
29691838 PubMed citation Europe PMC
29857005 PubMed citation Europe PMC
30036660 PubMed citation Europe PMC
30122837 PubMed citation Europe PMC
30142367 PubMed citation Europe PMC
30296470 PubMed citation Europe PMC
30731113 PubMed citation Europe PMC
30964192 PubMed citation Europe PMC
31121196 PubMed citation Europe PMC
31199948 PubMed citation Europe PMC
31231491 PubMed citation Europe PMC
31255353 PubMed citation Europe PMC
31385138 PubMed citation Europe PMC
31486512 PubMed citation Europe PMC
31502009 PubMed citation Europe PMC
31513835 PubMed citation Europe PMC
31595589 PubMed citation Europe PMC
31637897 PubMed citation Europe PMC
31821012 PubMed citation Europe PMC
31932110 PubMed citation Europe PMC
31965512 PubMed citation Europe PMC
32207519 PubMed citation Europe PMC
32271399 PubMed citation Europe PMC
32368015 PubMed citation Europe PMC
Last Modified
07 May 2020